Fetomaternal outcomes in liver disorders of pregnancy: a retrospective study from South India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262541Keywords:
Acute viral hepatitis, Adverse maternal outcome, Fetomaternal outcome, HELLP syndrome, Liver disease in pregnancyAbstract
Background: Liver disorders in pregnancy are rare but can cause life-threatening maternal and fetal complications. They arise from physiological, pregnancy-specific, or coincidental systemic diseases. This study aimed to analyze the etiological spectrum, biochemical profile, and fetomaternal outcomes among pregnant women with hepatic dysfunction at a tertiary-care center in Tamil Nadu.
Methods: A retrospective observational study was conducted between June 2024 and May 2025 in the department of obstetrics and gynecology, Government Medical College, Tiruvannamalai. All pregnant women with clinical or biochemical evidence of liver dysfunction were included. Data on symptomatology, etiology, biochemical parameters, complications, and fetomaternal outcomes were recorded. Statistical analyses included χ2 tests and ROC curve analysis of serum bilirubin, transaminases, and LDH as predictors of maternal complications.
Results: Among 12,542 deliveries, 65 (0.5 %) women had liver disorders. Mean age was 25 years; 73.8% presented in the third trimester. The commonest causes were viral hepatitis (52.3%), HELLP syndrome (16.9%), and hyperemesis gravidarum (13.8%). Maternal complications included postpartum hemorrhage (23%), DIC (9%), and hepatorenal syndrome (15%). There were no maternal deaths. Of 57 live births, 12% were preterm and three fetuses had intra-uterine death. ROC analysis showed LDH (AUC 0.82) as the best predictor of adverse maternal outcomes.
Conclusions: Liver disease in pregnancy remains a significant threat to fetomaternal health. Elevated LDH serves as a reliable biochemical marker of severity. Early diagnosis and multidisciplinary management are key to preventing mortality.
Metrics
References
Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, Majurec I, Brncic-Fischer A, Sobocan N. Liver disease during pregnancy: A challenging clinical issue. Med Sci Monit. 2018;24:4080-90. DOI: https://doi.org/10.12659/MSM.907723
Goel A, Jamwal KD, Ramachandran A, Balasubramanian KA, Eapen CE. Pregnancy-related liver disorders. J Clin Exp Hepatol. 2014;4(2):151-62. DOI: https://doi.org/10.1016/j.jceh.2013.03.220
Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111(2):176-94. DOI: https://doi.org/10.1038/ajg.2015.430
Ch’ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51(6):876-80. DOI: https://doi.org/10.1136/gut.51.6.876
Solanke D, Rathi C, Pandey V, Patil M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: a prospective study from western India. Indian J Gastroenterol. 2016;35(6):450-8. DOI: https://doi.org/10.1007/s12664-016-0704-6
Rasheeda CA, Navaneethan U, Jayanthi V. Liver disease in pregnancy and its influence on maternal and fetal mortality: a prospective study from Chennai, Southern India. Eur J Gastroenterol Hepatol. 2008;20(4):362-4. DOI: https://doi.org/10.1097/MEG.0b013e3282f246d6
Murali AR, Devarbhavi H, Venkatachala PR, Singh R, Sarin SK. Factors that predict 1-month mortality in patients with pregnancy-specific liver disease. Clin Gastroenterol Hepatol. 2014;12(1):109-13. DOI: https://doi.org/10.1016/j.cgh.2013.06.018
Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome- a prospective study. Indian J Gastroenterol. 2007;26(2):59-63.
Sharma S, Aherwar R, Jawade S. Maternal and fetal outcome in jaundice complicating pregnancy: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2016;5(4):1084-7. DOI: https://doi.org/10.18203/2320-1770.ijrcog20160862
Tiwari A, Aditya V, Srivastava R, Gupta G. A study of spectrum and outcome of liver diseases in pregnant women at BRD Medical College. Int J Reprod Contracept Obstet Gynecol. 2017;6(8):3641-5. DOI: https://doi.org/10.18203/2320-1770.ijrcog20173501
Jain M, Thaker H. Fetomaternal outcome of hepatic disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2019;8:1182-5. DOI: https://doi.org/10.18203/2320-1770.ijrcog20190902
Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933-45. DOI: https://doi.org/10.1016/j.jhep.2015.11.030
Panchbudhe SA, Parulekar M, Kudale S. Liver disease in pregnancy: a prospective analysis of maternal and fetal outcomes among 120 patients at a tertiary care center. J South Asian Feder Obstet Gynecol. 2022;14(5):551-6. DOI: https://doi.org/10.5005/jp-journals-10006-2137
Ramola M, Jain S, Gupta V, Bansal N, Singh P. Overview of liver disorders during pregnancy at a tertiary care centre: Uttarakhand scenario. Int J Reprod Contracept Obstet Gynecol. 2017;6:3979-82. DOI: https://doi.org/10.18203/2320-1770.ijrcog20174048
Konareddy T, Krithika K. Jaundice in pregnancy: a clinical study at JSS Hospital, Mysuru. Int J Reprod Contracept Obstet Gynecol. 2016;5:2257-60. DOI: https://doi.org/10.18203/2320-1770.ijrcog20162105
Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209(5):456.e1-7. DOI: https://doi.org/10.1016/j.ajog.2013.07.006
Rathi C, Pipaliya N, Phadke A, Ingle M, Patel P, Sawant P. Spectrum of liver disorders in pregnancy from western India. Indian J Gastroenterol. 2015;34(3):216-24.
Alghamdi S, Fleckenstein J. Liver disease in pregnancy and transplant. Curr Gastroenterol Rep. 2019;21(9):43. DOI: https://doi.org/10.1007/s11894-019-0711-8
Downloads
Published
How to Cite
Issue
Section
